Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update
Patrick F. van Rheenen, Marina Aloi, Amit Assa, et al.
Journal of Crohn s and Colitis (2020) Vol. 15, Iss. 2, pp. 171-194
Open Access | Times Cited: 484

Showing 1-25 of 484 citing articles:

ESPEN guideline on Clinical Nutrition in inflammatory bowel disease
Stephan C. Bischoff, Palle Bager, Johanna C. Escher, et al.
Clinical Nutrition (2023) Vol. 42, Iss. 3, pp. 352-379
Open Access | Times Cited: 169
Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts
Timon E. Adolph, Jingwan Zhang
Gut (2022) Vol. 71, Iss. 12, pp. 2574-2586
Open Access | Times Cited: 71
ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment
Hannah Gordon, Silvia Minozzi, Uri Kopylov, et al.
Journal of Crohn s and Colitis (2024)
Open Access | Times Cited: 49
Navigating the complexities of drug development for inflammatory bowel disease
Sailish Honap, Vipul Jairath, Silvio Danese, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 546-562
Closed Access | Times Cited: 21
Chronisch-entzündliche Darmerkrankungen bei Kindern und Jugendlichen
Tobias Schwerd
Deleted Journal (2025)
Open Access | Times Cited: 1
Metagenome-informed metaproteomics of the human gut microbiome, host, and dietary exposome uncovers signatures of health and inflammatory bowel disease
Rafael Valdés‐Mas, Avner Leshem, Danping Zheng, et al.
Cell (2025)
Closed Access | Times Cited: 1
Not All Fibers Are Born Equal; Variable Response to Dietary Fiber Subtypes in IBD
Heather Armstrong, I K Mander, Zhengxiao Zhang, et al.
Frontiers in Pediatrics (2021) Vol. 8
Open Access | Times Cited: 74
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004
Andreas Sturm, Andreas Stallmach, Raja Atreya, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 03, pp. 332-418
Closed Access | Times Cited: 63
The Use of Fecal Calprotectin Testing in Paediatric Disorders
Carmen Ribes‐Koninckx, Ester Donat, Marc A. Benninga, et al.
Journal of Pediatric Gastroenterology and Nutrition (2021) Vol. 72, Iss. 4, pp. 617-640
Open Access | Times Cited: 60
Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
Nghia Nguyen, Virginia Solitano, Sudheer K. Vuyyuru, et al.
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 937-949.e2
Open Access | Times Cited: 45
Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study
Ohad Atia, Zivia Shavit-Brunschwig, Diane R. Mould, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 8, Iss. 1, pp. 31-42
Closed Access | Times Cited: 39
Intestinal ultrasound as a non-invasive tool to monitor inflammatory bowel disease activity and guide clinical decision making
Michael Dolinger, Maia Kayal
World Journal of Gastroenterology (2023) Vol. 29, Iss. 15, pp. 2272-2282
Open Access | Times Cited: 38
Inflammatory bowel disease: recent developments
James J. Ashton, R. Mark Beattie
Archives of Disease in Childhood (2023) Vol. 109, Iss. 5, pp. 370-376
Open Access | Times Cited: 25
A Model-Based Tool for Guiding Infliximab Induction Dosing to Maximize Long-term Deep Remission in Children with Inflammatory Bowel Diseases
W Kantasiripitak, Sebastian G. Wicha, Debby Thomas, et al.
Journal of Crohn s and Colitis (2023) Vol. 17, Iss. 6, pp. 896-908
Open Access | Times Cited: 21
Enteral nutrition promotes the remission of colitis by gut bacteria-mediated histidine biosynthesis
Wanyi Zeng, Jinjie Wu, Hongyu Xie, et al.
EBioMedicine (2024) Vol. 100, pp. 104959-104959
Open Access | Times Cited: 8
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline
Andreas Sturm, Raja Atreya, Dominik Bettenworth, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 08, pp. 1229-1318
Open Access | Times Cited: 7
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
Laurent Peyrin‐Biroulet, William J. Sandborn, Remo Panaccione, et al.
Therapeutic Advances in Gastroenterology (2021) Vol. 14
Open Access | Times Cited: 41
Nutritional Therapy Strategies in Pediatric Crohn’s Disease
Charlotte M. Verburgt, Mohammed Ghiboub, Marc A. Benninga, et al.
Nutrients (2021) Vol. 13, Iss. 1, pp. 212-212
Open Access | Times Cited: 40
Point-of-Care Testing and Home Testing: Pragmatic Considerations for Widespread Incorporation of Stool Tests, Serum Tests, and Intestinal Ultrasound
Rune Wilkens, Michael Dolinger, Johan Burisch, et al.
Gastroenterology (2022) Vol. 162, Iss. 5, pp. 1476-1492
Open Access | Times Cited: 30
Metabolome Changes With Diet-Induced Remission in Pediatric Crohn’s Disease
Mohammed Ghiboub, Susanne Penny, Charlotte M. Verburgt, et al.
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 922-936.e15
Closed Access | Times Cited: 29
Dual Biologic or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease (DOUBLE-PIBD): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN
Anat Yerushalmy‐Feler, Christine Olbjørn, Kaija‐Leena Kolho, et al.
Inflammatory Bowel Diseases (2023)
Closed Access | Times Cited: 19
Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years
Marcello Imbrizi, Fernando Magro, Cláudio Saddy Rodrigues Coy
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1272-1272
Open Access | Times Cited: 18
Fiber-deficient diet inhibits colitis through the regulation of the niche and metabolism of a gut pathobiont
Peter Kuffa, Joseph M. Pickard, Austin Campbell, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 12, pp. 2007-2022.e12
Open Access | Times Cited: 18
The Crohn’s Disease Exclusion Diet: A Comprehensive Review of Evidence, Implementation Strategies, Practical Guidance, and Future Directions
Rotem Sigall Boneh, Catherine Westoby, Ilan Oseran, et al.
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 10, pp. 1888-1902
Open Access | Times Cited: 17
Durability of Adalimumab and Infliximab in Children With Crohn’s Disease: A Nationwide Comparison From the epi-IIRN Cohort
Ohad Atia, C Friss, Gili Focht, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. 11, pp. 2097-2104
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top